U.S. Auto Components Stock News

NYSE:GAP
NYSE:GAPSpecialty Retail

Dividend Hike And Encore Loyalty Launch Could Be A Game Changer For Gap (GAP)

Gap Inc. recently increased its first-quarter fiscal 2026 dividend to US$0.175 per share, a 6% raise over the prior quarter, and rolled out its Encore loyalty program across Old Navy, Gap, Banana Republic, and Athleta with tiered rewards and exclusive experiences. Together, the richer dividend and Encore launch highlight Gap’s current focus on deepening customer relationships while also directing more cash back to shareholders. Next, we’ll examine how the Encore loyalty rollout could...
NYSE:WTM
NYSE:WTMInsurance

White Mountains Insurance Group (WTM) Valuation Check After Strong Recent Shareholder Returns

White Mountains Insurance Group (WTM) has drawn investor attention after recent share price moves, with the stock’s one-month and past three-month returns outpacing its one-day and seven-day performance. See our latest analysis for White Mountains Insurance Group. Those short term moves sit within a stronger backdrop, with the 30 day share price return of 8.31% and year to date share price return of 8.87% aligning with a 1 year total shareholder return of 20.79%. This suggests momentum has...
NasdaqGS:OS
NasdaqGS:OSSoftware

Assessing OneStream (OS) Valuation After Recent Share Price Momentum And DCF Signals

How OneStream (OS) Has Been Trading Recently With no single headline event driving OneStream (OS) today, investors are instead weighing its recent share performance, revenue profile, and current losses to assess how the stock fits into their software exposure. See our latest analysis for OneStream. At a recent share price of $23.60, OneStream sits on a 90 day share price return of 13.3% and a year to date share price return of 33.18%, while the 1 year total shareholder return is 3.1%. This...
NasdaqGS:TEM
NasdaqGS:TEMLife Sciences

Tempus AI Expands Oncology Portfolio With HRD-RNA And Lung Screening Deal

Tempus AI (NasdaqGS:TEM) has launched its HRD-RNA algorithm, designed to identify Homologous Recombination Deficiency in cancer using RNA data. The company also announced a partnership with Median Technologies to bring the eyonis LCS AI lung cancer screening tool to markets in the US and Europe. Tempus AI, which last closed at $55.41, is adding new tools to its precision oncology and early detection portfolio with the HRD-RNA algorithm and the eyonis LCS AI screening partnership. The stock...
NYSE:CNM
NYSE:CNMTrade Distributors

How the Projected 45% EPS Jump Before Earnings Could Shape Core & Main’s (CNM) Investment Narrative

Core & Main recently drew investor attention ahead of its past earnings release, where the company’s quarterly EPS was projected at US$0.48, implying a very large year-over-year increase of 45.45% and highlighting strong expectations for profit improvement. This projection, combined with ongoing shifts in analyst estimates, underlined how quickly views on Core & Main’s short-term business trends can change as new information emerges. We’ll now explore how the projected EPS jump for that past...
NasdaqGS:WSBC
NasdaqGS:WSBCBanks

Assessing WesBanco (WSBC) Valuation After Fresh Analyst Buy Ratings And Steady Dividend Policy

Analyst attention and dividend moves put WesBanco (WSBC) in focus Fresh coverage from DA Davidson, which initiated on WesBanco (WSBC) with a positive stance alongside generally favorable broker views, has sharpened investor attention on the regional bank’s income profile and recent dividend decisions. At the same time, WesBanco’s Board reaffirmed its commitment to cash returns by declaring a quarterly common dividend of $0.38 per share, along with a scheduled payout on its 7.375%...
NasdaqGS:TIGO
NasdaqGS:TIGOWireless Telecom

Has Millicom (TIGO) Run Too Far After 198% One-Year Surge?

If you are wondering whether Millicom International Cellular is priced attractively after its recent run, this article will help you assess what you might actually be paying for. The stock last closed at US$70.68, with returns of 7.0% over 7 days, 16.2% over 30 days, 25.0% year to date, 198.4% over 1 year, 323.1% over 3 years and 166.1% over 5 years, which naturally raises questions about how its current price lines up with its fundamentals. Recent coverage around Millicom has focused on its...
NasdaqGS:TER
NasdaqGS:TERSemiconductor

Assessing Teradyne (NasdaqGS:TER) Valuation After Strong AI Test Demand And Earnings Beat

Teradyne (TER) is back in focus after reporting quarterly results that beat estimates, supported by strong demand for its AI linked semiconductor test and robotics products and growing attention on the upcoming April earnings update. See our latest analysis for Teradyne. That earnings beat and Teradyne’s AI focused exposure are lining up with a powerful price move, with a 39.24% 1 month share price return and 206.9% 1 year total shareholder return, which suggests momentum has been building...
NYSE:FDP
NYSE:FDPFood

Did Margin Gains and Capital Returns Just Shift Fresh Del Monte Produce's (FDP) Investment Narrative?

In February 2026, Fresh Del Monte Produce’s board declared a quarterly cash dividend of US$0.30 per share, payable on March 27 to shareholders of record as of March 4, and reported fourth-quarter 2025 sales of US$1,019.5 million with net income of US$31.9 million. The company coupled this dividend and earnings release with details of its completed share repurchase program and a sharper focus on core, higher-return categories that lifted quarterly profitability despite largely flat sales. Now...
NasdaqGS:CGNX
NasdaqGS:CGNXElectronic

Cognex Board Refresh Brings Automation And Sales Focus Into Spotlight

Cognex (NasdaqGS:CGNX) has added Dr. Sami Atiya and Chris Donato to its board of directors. Both bring leadership backgrounds from large technology and automation companies including ABB, Siemens, Zendesk and Oracle. Former CEO Robert Willett and one other long-serving director are set to retire from the board. Cognex, trading at $55.36, has seen strong recent share price moves, with the stock up 40.3% over the past 30 days and 49.9% year to date. Over the past year, shares are up 70.6%,...
NYSE:TPR
NYSE:TPRLuxury

Tapestry (TPR) Is Up 5.4% After AI-Driven Outlook Upgrade And Net-Zero Push - What's Changed

In recent months, Tapestry, the parent of Coach and Kate Spade, raised its fiscal 2026 outlook, highlighting higher-than-expected revenue and earnings expectations supported by AI-enabled demand forecasting, inventory optimization, and a reinforced direct-to-consumer model. At the same time, the company has been sharpening its brand and sustainability profile through its largest Gen Z-focused marketing campaign and a 10-year carbon-removal partnership with Climeworks aimed at progressing...
NYSE:XYZ
NYSE:XYZDiversified Financial

Block Resets Workforce While Expanding Accessibility And Testing Investor Patience

Block (NYSE:XYZ) is cutting its workforce by more than 40% as part of a broad restructuring of its operating model. The company is reshaping teams and processes to align more closely with updated priorities across its ecosystem. In parallel, Square has partnered with Pages & Pages, a retail business run by blind and low vision entrepreneurs, to expand accessibility in payments and in store experiences. Block enters this reset with its shares at $54.53 and a mixed recent track record,...
NYSE:ACN
NYSE:ACNIT

US Stock Market Today S&P 500 Futures Ease As Housing And Factory Signals Diverge

The Morning Bull - US Market Morning Update Friday, Feb, 27 2026 US stock futures are pointing slightly lower this morning, with E-mini S&P 500 futures down about 0.2%, as investors weigh cheaper borrowing costs against mixed global growth signals. The 30 year US mortgage rate has dipped below 6% to 5.98%, which can make monthly payments a bit less painful and puts housing related names in focus. At the same time, the Kansas Fed Manufacturing Index has bounced to 10, a sign that factory...
NasdaqGS:AMLX
NasdaqGS:AMLXPharmaceuticals

Amylyx Pharmaceuticals (AMLX) Valuation Check After Mixed Recent Share Price Performance

Amylyx Pharmaceuticals (AMLX) stock in focus Amylyx Pharmaceuticals (AMLX) has drawn investor attention after a period where the shares show a small loss over the past month, yet a gain over the past 3 months and year to date. See our latest analysis for Amylyx Pharmaceuticals. The recent 6.2% 1 day and 8.8% 7 day share price returns contrast with a 1.4% 30 day share price decline. At the same time, the 33.6% year to date share price return and very large 1 year total shareholder return...
NYSE:PH
NYSE:PHMachinery

Assessing Parker-Hannifin (PH) Valuation After Strong Share Price Momentum And Earnings Narrative

Why Parker-Hannifin (PH) is on investors’ radar today Parker-Hannifin (PH) is back in focus after a recent share price move, with the stock last closing at US$1,014.97. That puts fresh attention on how its fundamentals line up at this level. See our latest analysis for Parker-Hannifin. The recent move to US$1,014.97 comes after a strong run, with a 30 day share price return of 9.61% and a 90 day share price return of 17.79%, alongside a 1 year total shareholder return of 56.39% that points to...
NasdaqGS:QDEL
NasdaqGS:QDELMedical Equipment

Should QuidelOrtho’s (QDEL) Lifotronic Immunoassay Expansion Require Action From QDEL Investors?

QuidelOrtho recently announced a long-term supply agreement with Lifotronic Technology to broaden its immunoassay analyzer platforms and add over 70 assays, including more than 25 not currently offered on its VITROS system, across select markets outside the United States. This collaboration could materially reshape QuidelOrtho’s international diagnostics offering by helping it compete for full‑menu tenders and better serve both small and high‑throughput laboratories. Next, we’ll examine how...
OTCPK:SBNC
OTCPK:SBNCBanks

Southern BancShares (N.C.) (OTCPK:SBNC) Margin Reset To 34.9% Tests Bullish Narratives

Southern BancShares (N.C.) (SBNC) has just wrapped up FY 2025 with fourth quarter revenue of US$122.7 million and basic EPS of US$912.54, capping a 12 month stretch where trailing revenue came in at US$195.5 million and EPS was US$901.30. Over recent quarters, the bank has seen revenue move from US$74.6 million and EPS of US$507.05 in Q3 FY 2024 to US$70.5 million and EPS of US$450.53 in Q2 FY 2025, before landing at the latest Q4 figures. Trailing net profit margin over the year sits at...
NYSE:U
NYSE:USoftware

Is Unity Software (U) Offering An Opportunity After Recent Share Price Weakness

If you are wondering whether Unity Software's share price still reflects its underlying worth, you are not alone. This article is set up to help you frame that question more clearly. Unity closed at US$19.58, with a 5.9% move over the last 7 days. The 30 day, year to date and 1 year returns of 52.5%, 55.8% and 25.2% declines highlight how sentiment has shifted over different timeframes. Recent news on Unity has focused on ongoing interest in its role as a key platform for real time 3D...
NasdaqGS:PRAX
NasdaqGS:PRAXBiotechs

How Investors Are Reacting To Praxis (PRAX) Wider Losses, Fresh NDAs And Multi‑Year Cash Runway

In February 2026, Praxis Precision Medicines reported that its net loss widened to US$88.91 million for the fourth quarter and US$303.27 million for 2025, while basic loss per share from continuing operations rose to US$3.50 for the quarter and US$13.48 for the year. At the same time, Praxis filed New Drug Applications for ulixacaltamide and relutrigine, signaling a move toward potential commercialization backed by late-stage data and a cash position of about US$1.50 billion that management...
NasdaqCM:SLNO
NasdaqCM:SLNOBiotechs

Soleno Therapeutics Q4 Profitability Milestone Tests High P/E Narrative

Soleno Therapeutics (SLNO) just closed out FY 2025 with fourth quarter revenue of US$91.7 million and basic EPS of US$0.81, alongside net income of US$42.9 million. This capped a trailing 12 month line that shows revenue of US$190.4 million and basic EPS of US$0.40. The company reported revenue of US$66.0 million in Q3 and US$32.7 million in Q2, while EPS moved from US$0.49 in Q3 and a small loss in Q2. Together, these figures describe a story where higher sales and a cleaner income line are...
NYSE:MS
NYSE:MSCapital Markets

Morgan Stanley Expands Security And Private Markets Fee Engines With New Moves

Morgan Stanley Capital Partners agreed to acquire Security 101, a U.S. security integration provider serving sectors such as healthcare, government, and finance. EquityZen, a private shares marketplace acquired by Morgan Stanley Wealth Management in January, is cutting transaction fees for investors and shareholders on its platform. These moves highlight Morgan Stanley's effort to expand its security integration footprint and adjust its financial technology offerings for clients. Morgan...
NYSE:AMTM
NYSE:AMTMProfessional Services

Is Amentum (AMTM) Quietly Rewriting Its Defense Narrative With UK Hypersonics And Fixed‑Price Deals?

Amentum Holdings recently secured an Industry Mission Partner contract from the UK Ministry of Defence’s Team Hypersonics to provide missile design engineering and program management for hypersonic strike capabilities under the AUKUS framework, while also reporting a steady start to FY2026 with 3% normalized growth and around US$1.00 billion in nuclear energy awards in FQ1. These developments, alongside progress integrating its 2024 merger with Jacobs Solutions and a shift toward...
NYSE:DCO
NYSE:DCOAerospace & Defense

Ducommun (DCO) Swings Back To Quarterly Profit But Trailing Loss Tests Bullish Narratives

Ducommun (DCO) has wrapped up FY 2025 with fourth quarter revenue of US$215.8 million and basic EPS of US$0.50, alongside net income of US$7.4 million. The trailing twelve month figures show revenue of US$824.7 million and a net loss of US$33.9 million tied to basic EPS of US$2.27. Over recent quarters, revenue has moved from US$197.3 million in Q4 2024 to US$215.8 million in Q4 2025, with quarterly basic EPS ranging from a loss of US$4.30 in Q3 2025 to a profit of US$0.50 in Q4 2025. For...
NYSE:NBR
NYSE:NBREnergy Services

Is Nabors Industries (NBR) Still Attractive After A 95% One-Year Share Price Surge?

If you are wondering whether Nabors Industries shares still offer value at around US$77.80, you are not alone. The answer depends on how you look at the numbers. The stock has recently shown sharp moves, with returns of 1.6% over the past week, 15.7% over the last month, 40.4% year to date and 95.5% over the past year. The 3 year and 5 year returns sit at 51.0% and 31.9% declines respectively. These swings have kept Nabors Industries on the radar of investors who track companies where...